Brinckerhoff Quoted on Biosimilar Sponsors

24 July 2015 BioWorld News


Partner Courtenay Brinckerhoff was quoted in a BioWorld article, “With BPCIA Dance Optional, Next Moves Up to Biosimilar Sponsors,” on July 24, 2015. The article discussed next steps for biosimilar sponsors after the Federal Circuit confirmed that the Biologic Price Competition and Innovation Act’s intricate patent information exchange is optional. Brinckerhoff said it’s likely that many biosimilar developers will choose not to follow the steps in place by BPCIA since it requires the biosimilar sponsor to give a copy of its application and other confidential manufacturing-related information to the reigning market champion.

Related Services


Hatch Comments on DNC-Related Construction Projects in Milwaukee
14 June 2019
Milwaukee Business Journal
Bernard Quoted on Debt-Relief Settlement with ITT Tech Lender
14 June 2019
Wall Street Journal
Dodd and Daughter Profiled in Wisconsin Golf
13 June 2019
Wisconsin Golf
Brinckerhoff Comments on SCOTUS Ruling in Patent Case
11 June 2019
Intellectual Property Magazine
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ
Foley's Government Contracts Annual Update
16 October 2019
Liviona, MI